Loading Phase (Weeks 1-4): 2 to 2.5 mg twice weekly (Monday/Thursday schedule) Maintenance Phase (Weeks 5+): 2 mg once every 7 to 14 days Administration: Subcutaneous injection, location flexible due to systemic distribution Total Cycle: 8 to 12 weeks with 4 to 8 weeks off between cycles The convenience of twice-weekly dosing during loading and weekly or biweekly dosing during maintenance fits easily into Retatrutide schedules
The lowered tolerance maps onto altered absorption and slower metabolism
Protein-rich meals, fiber, short-chain fatty acids from fermented foods, and certain polyphenols all increase endogenous GLP-1 secretion
These insights can help your provider tailor starting dose and titration pace, potentially reducing wasted spending on mismatched protocols and supporting faster route to an effective, affordable regimen
Back Okunogbe, A, Nugent, R, Spencer, G, et al (Oct 2021) 'Economic impacts of overweight and obesity: current and future estimates for eight countries', British Medical Journal Global Health , 6/10, Back rskov, C, Bersani, M, Johnson, AH, et al (5 August 1989) 'Complete sequences of glucagon-like peptide-1 from human and pig small intestine', Journal of Biological Chemistry , 264/22, 12826-9
Overall, these results may be used for preliminary MNT guidance for this population, and the researchers call for future large-scale studies to confirm these findings and develop more specific nutritional protocols that account for the unique needs of GLP-1RA users